PureTech Health (PRTC) Receivables (2019 - 2025)

PureTech Health (PRTC) has 7 years of Receivables data on file, last reported at $1.8 million in Q4 2025.

• Receivables for Q4 2025 came in at $1.8 million, up 699.09% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.8 million (up 699.09% YoY), and the FY2025 annual result was $1.8 million, up 699.09% from the prior year.
• Receivables advanced to $1.8 million in Q4 2025 per PRTC's latest filing, from $220000.0 in the prior quarter.
• Over five years, Receivables peaked at $3.6 million in Q4 2021 and troughed at $220000.0 in Q4 2024.
• A 5-year average of $1.3 million and a median of $702000.0 in 2023 frame the typical range for Receivables.
• The sharpest annual moves came in 2022 and 2025: Receivables sank 87.46% in 2022, then soared 699.09% in 2025.
• A 5-year view of Receivables shows it stood at $3.6 million in 2021, then slumped by 87.46% to $450000.0 in 2022, then soared by 56.0% to $702000.0 in 2023, then slumped by 68.66% to $220000.0 in 2024, then soared by 699.09% to $1.8 million in 2025.
• Business Quant data shows PRTC's Receivables at $1.8 million in Q4 2025, $220000.0 in Q4 2024, and $702000.0 in Q4 2023.